Decoding POAI: Analyzing Predictive Oncology’s Q4 2023 Financial Performance

Avatar photo
POAI stock - POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023

Source: iQoncept / Shutterstock

Predictive Oncology (NASDAQ:POAI) recently disclosed their financial performance for the fourth quarter of 2023.

  • The company showcased a loss of 85 cents per share.
  • Revealing revenue of $335,032.

InvestorPlace Earnings is harnessing data from TradeSmith to automate the coverage of quarterly earnings reports. It provides crucial insights such as earnings per share, revenue figures, and comparative analysis against analyst predictions. These reports are generated sans human intervention, offering our readers swift access to the latest financial data. Reach out to us at [email protected] to address any concerns or inaccuracies.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/poai-stock-earnings-predictive-oncology-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now